NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Results

Rhea-AI Summary

NuVasive, Inc. (NASDAQ: NUVA) will release its fourth quarter and full year 2020 earnings results on February 25, 2021, after market close. A conference call will occur at 4:30 p.m. ET to discuss the financial performance. Domestic callers can dial 1-800-954-0604, while international callers can use 1-312-281-1210. The call will be available for replay until March 4, 2021. NuVasive focuses on minimally invasive spine technology, boasting over $1 billion in net sales and operations in more than 50 countries.

Positive

• NuVasive is a leader in spine technology, indicating strong market positioning.
• The upcoming earnings report could provide insights into the company's financial health and growth potential.
• With a diverse portfolio and global reach, the company has access to a broad market.

Negative

• Risks related to net sales and earnings projections due to uncertainties in product sales.
• Potential for adjustments to financial results can impact investor confidence.
• Forward-looking statements indicate uncertainty in achieving projected profitability.

SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its fourth quarter and full year 2020 earnings results on Thursday, February 25, 2021, after the close of the market.

NuVasive will hold a conference call on Thursday, February 25, 2021, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the fourth quarter and full year 2020. The dial-in numbers are 1-800-954-0604 for domestic callers and 1-312-281-1210 for international callers. A live webcast of the conference call will be available online from the Investor Relations page of the Company's website at www.nuvasive.com.

After the live webcast, the call will remain available on NuVasive's website through March 25, 2021. In addition, a telephone replay of the call will be available until March 4, 2021. The replay dial-in numbers are 1-844-512-2921 for domestic callers and 1-412-317-6671 for international callers. Please use pin number: 21990639.

About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive has approximately 2,700 employees and operates in more than 50 countries serving surgeons, hospitals and patients. For more information, please visit www.nuvasive.com. 

Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, but are not limited to, the risk that NuVasive's net sales or earnings projections may turn out to be inaccurate because of the preliminary nature of the forecasts; the risk of further adjustment to financial results or future financial expectations; unanticipated difficulty in selling products, generating net sales or producing expected profitability; and those other risks and uncertainties more fully described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

View original content to download multimedia:http://www.prnewswire.com/news-releases/nuvasive-announces-conference-call-and-webcast-of-fourth-quarter-and-full-year-2020-results-301226570.html

SOURCE NuVasive, Inc.

FAQ

When will NuVasive release its fourth quarter and full year 2020 earnings results?

NuVasive will release its earnings results on February 25, 2021, after market close.

What time will NuVasive's conference call take place?

The conference call will take place at 4:30 p.m. ET on February 25, 2021.

How can I listen to NuVasive's conference call?

You can listen to the conference call by dialing 1-800-954-0604 for domestic calls or 1-312-281-1210 for international calls.

What are the risks mentioned in NuVasive's press release?

The risks include uncertainties in net sales and earnings projections, which may impact financial results.